NanoViricides
NNVC
54 hedge funds and large institutions have $15.3M invested in NanoViricides in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 6 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 8
39% more call options, than puts
Call options by funds: $97K | Put options by funds: $70K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
2% more funds holding
Funds holding: 53 → 54 (+1)
0% more ownership
Funds ownership: 0.48% → 0.48% (+0%)
8% less capital invested
Capital invested by funds: $16.7M → $15.3M (-$1.39M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$770K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$601K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$180K |
| 4 |
State Street
Boston,
Massachusetts
|
+$126K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$97.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
-$1.3M |
| 2 |
Goldman Sachs
New York
|
-$141K |
| 3 |
WAM
Weatherly Asset Management
Del Mar,
California
|
-$128K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$111K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$67.5K |
NNVC Hedge Fund Activity: Q4 2014 in Review
54 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2014, worth a combined $15.3M — down 8.3% from $16.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NNVC positions and 6 closed out — a net gain of 2 holders — while 22 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $770K. The largest seller was Colony Group, exiting entirely with an estimated $1.3M sold.
- 54 institutional investors held NanoViricides (NNVC) as of Q4 2014, up from 53 in Q3 2014.
- Funds reported $15.3M of NanoViricides stock for Q4 2014, down 8.3% quarter-over-quarter.
- 8 funds opened new NanoViricides positions in Q4 2014 and 6 closed out, a net change of +2 holders.
- The largest NanoViricides buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $770K added.
- The largest NanoViricides seller in Q4 2014 was Colony Group, an estimated $1.3M sold.
Based on aggregated 13F filings for Q4 2014.